Health Policy
When the SHA Allocation Runs Out
There is a word that has entered the vocabulary of cancer in Kenya, and it is not a medical word. It is allocation. A woman sits in the oncology ward at Kenyatta National Hospital, her chemotherapy interrupted mid-course, and she is not told that her cancer has changed or that her body has failed. She is told that her allocation has run out. The disease is indifferent to this news. The tumour does not pause to consult the ledger. Only the treatment pauses — because the money, and not the medicine, has reached its limit.
This is the quiet cruelty at the centre of Kenya’s cancer financing: we have built a system in which the accountant, not the oncologist, decides when treatment ends. And the accountant decides early. A survey placed before the National Assembly’s Health Committee found that sixty per cent of cancer patients exhaust their SHA cover before the year is out — and more damning still, that 35.8 per cent are abandoned by their benefit in under three months. Three months. A single diagnosis, a few cycles of chemotherapy, and the patient is returned to the cash economy of survival: borrowing from relatives, selling land, going without.
The tumour does not pause to consult the ledger. Only the treatment pauses.
I have written before about the patients told to wait — to wait weeks, to wait months, sometimes to wait for a fund that will not arrive in time to matter. This essay is about the machinery that produces that waiting, and about the single design decision that guarantees it. The machinery has a name. It is the cap.
Let me concede what honesty requires, because a concession made plainly is what earns the right to the harder argument. Uncapping cancer care is not free. Every health system on earth rations something, and a ceiling is a rationing device; to pretend that Kenya can simply declare an infinite pool and walk away is to argue like a child, and I will not insult the Treasury by doing so. The Ministry’s dilemma is real. It supports some thirty-five thousand cancer patients today while its own data suggests the true number is nearer fifty thousand, and it must do this from a pool that does not expand merely because the diagnoses do. Grant all of it. But a concession is not a surrender. To admit that money is finite is not to admit that the sick person is the right place to store the shortfall.
Because here is what the Ministry will do with a demand phrased simply as remove the cap. It will remove it — on paper. Kenya already carries an uncapped promise written into its own law: the Emergency, Chronic and Critical Illness Fund, the very mechanism meant to catch the patient once the Social Health Insurance Fund is spent. And what has that uncapped promise delivered? Patients told to wait two years for a fund that treats a disease measured in weeks.
An entitlement with no money behind it is not an entitlement. It is a cruelty with better paperwork.
We have watched this performance at the highest level. On the first of December 2025, the President stood and announced that the oncology package would rise from Sh550,000 to Sh800,000. World Cancer Day 2026 came and went, and the hospitals still turned patients to the cashier — because SHA had not gazetted the tariffs that would make the President’s words operative. A promise the machinery does not honour is not a promise. It is a proclamation. De jure generosity; de facto abandonment. This is precisely what “remove the cap” buys us if we ask for nothing more exact: the gazette changes, and the waiting does not.
And if you doubt that the problem is money rather than words, look at the foundations. The Primary Health Care Fund — the fund responsible for screening, prevention, the early detection that makes cancer survivable — was allocated Sh4.1 billion against an identified requirement of Sh61 billion. A gap of ninety-three per cent. This is not a system that has run temporarily short. It is a system that was never funded to the size of its own promises, and then asked the patient to make up the difference with her body.
And we must be exact about what the reform actually did, because the government’s own defence collapses on the arithmetic. Under the defunct National Health Insurance Fund, a cancer patient held an individual oncology benefit of Sh680,000 a year. Under SHA, that became Sh550,000 — and no longer per patient, but per household. Read that twice. The reform did not merely cap the benefit; it lowered it, and then it made a mother and her child draw from the same shrunken well. A household with two patients is not covered. It is asked to choose which of its members the money is for. “Leaving no one behind” was the slogan. The ledger, in the government’s own figures, tells the opposite story.
So what do I actually ask for? Not the abolition of limits — the relocation of the limit. And here Germany, whose system I have lived beneath for two decades, offers Kenya four lessons. Not because Kenya is Germany, nor can be, but because the lessons are about architecture and habit, and neither is bought by wealth alone.
The first lesson disarms the objection that will be raised before any other: Germany is rich, and we are not. True — and yet Germany also rations. It simply rations in the right place. A committee, the Gemeinsamer Bundesausschuss, advised by an independent scientific institute, decides collectively what the pool will fund and negotiates the price it will pay for new medicines before a single euro is spent. The rationing is real, deliberate, and unsentimental. But it happens once, upstream, over what the system covers — never downstream, over an individual patient in the middle of her chemotherapy. That is the whole of the difference. Ration the system, not the sufferer.
The second lesson answers the objection outright. Germany sets no shilling ceiling on the cost of treating a cancer. What it caps instead is the patient’s exposure: the most a chronically ill person pays from her own pocket in a year is one per cent of her income. The cost of the medicine floats to whatever the disease demands; the burden on the patient is fixed, and humane. Now — Kenya may protest that it cannot afford so gentle a setting as one per cent. Then set it higher. The loss-cap is a dial, not a luxury. At any setting it still refuses to send a patient over a cliff; it only decides how steep the climb is on the way. A fixed shilling benefit-ceiling, by contrast, guarantees the cliff for every patient whose disease outruns the number. The principle costs nothing to adopt. Only its generosity scales with the budget.
Cap the loss, not the cure. Kenya caps the cure and lets the loss run wild.
The third lesson is about the pool behind the promise. Germany funds cancer from contributions gathered centrally and redistributed to its insurers by a formula weighted for how sick each insurer’s members actually are — so that the fund carrying the heaviest burden of illness is not the fund driven into ruin. The pool is sized to the disease, not to whatever sum survives the budget cycle. Hold that beside Kenya’s Emergency, Chronic and Critical Illness Fund: gazetted as a rescue, then starved until it told patients to wait two years. An uncapped promise is only ever as real as the fund standing behind it.
The fourth lesson is the one Kenya can begin tomorrow, and it costs the least while saving the most. It is not about the size of the pot at all. It is about a habit. German insurance does not wait for the patient to fall ill and then present her with a bill. It reaches for her first. From the age of thirty-five, every member is invited — by letter, at set ages, on a schedule the system itself keeps — to a general check-up and a skin examination. Women are screened for cervical cancer from their thirties and for breast cancer by mammography through the decades that follow. And from the age of fifty, the insurer pays for the endoscopy — the colonoscopy — that finds the polyp before it becomes the tumour and removes it in the same hour. I should be precise, because precision is the point: this participation is voluntary, not compelled. But the architecture is built to pull the member in. The invitation arrives whether she asks for it or not; the remembering is the state’s task, not the patient’s. The system does not merely permit early detection. It chases her down with it.
And here is the arithmetic that ought to command a finance ministry above all others: it is cheaper to find the cancer early than to fund it late. A colonoscopy that lifts out a polyp is a rounding error beside the millions that comprehensive treatment of the resulting cancer will cost. Every figure Kenya’s Treasury dreads — the exhausted allocation, the starved chronic-illness fund, the patient sent home to wait — sits downstream of a diagnosis made too late. Recall the Primary Health Care Fund, funded at Sh4.1 billion against a Sh61 billion need. We are starving the cheapest part of the system in order to ration the most expensive part of it.
It is cheaper to find the cancer early than to fund it late.
So a serious Kenyan early-diagnostic package — age-dependent screening with endoscopy at its centre, paid for by SHA as an ordinary entitlement and not left to the patient’s purse — is not charity, and it is not a frill for a richer country to enjoy. It is the single cheapest instrument the Ministry holds, and it is precisely the one it has chosen to underfund.
Return, then, to the cure, and to the number that shames the ceiling. The National Assembly’s own committee found that comprehensive treatment for a single cancer patient readily exceeds Sh3.8 million. Set that beside the Sh550,000 cover. The cap does not ration care at its margins; it funds barely one-seventh of the journey and sends the patient home. The remaining six-sevenths — some eighty-five shillings in every hundred — is left to relatives, to church fundraisers, to the sale of the family shamba, to the slow arithmetic of going without.
Yet the principle has already been conceded. A government that pays the premiums of 2.3 million vulnerable Kenyans — orphans, widows, the elderly, those with no income at all — has already accepted that health is a public charge and not a private misfortune. Having conceded the principle, it cannot now retreat behind the price. The only question that remains is whether the pool will be funded to the honest size of the need, or whether it will stay sized to whatever survives the budget cycle.
So this is my call to the Ministry of Health, and I will make it precise enough that it cannot be met with a gazette and an empty fund. Do not simply announce a higher ceiling; a ceiling reached in three months instead of two is only a longer walk to the same cliff. Do not gazette an uncapped entitlement and then starve the fund behind it, as the Chronic and Critical Illness Fund has already been starved. Do this instead: lift the ceiling off the patient and set it on the patient’s loss — a fixed, humane share of income beyond which no Kenyan is asked to pay; fund the pool to the actuarial size of the disease, and publish that costing so the nation may hold you to the figure; and put age-dependent screening, endoscopy included, at the centre of the benefit, because the cancer you find early is the cancer you can afford to cure.
The measure of a health system is not the elegance of its formulae, nor the generosity of its press releases. It is whether the woman in the oncology ward finishes her treatment or is sent home to wait. Health, not the ledger. Let the oncologist decide when treatment ends — never the accountant.
❧ Dr. rer. nat. habil. Dr. Seronei Chelulei Cheison ❧